2025
Stereotactic radiosurgery as neuromodulation of refractory angina: an initial case series
CVEK, Jakub; Otakar JIRAVSKÝ; Lukas KNYBEL; Miroslav HUDEC; Radim SPACEK et. al.Basic information
Original name
Stereotactic radiosurgery as neuromodulation of refractory angina: an initial case series
Authors
CVEK, Jakub (203 Czech Republic); Otakar JIRAVSKÝ (203 Czech Republic); Lukas KNYBEL (203 Czech Republic); Miroslav HUDEC (203 Czech Republic, belonging to the institution); Radim SPACEK (203 Czech Republic); Adrian REICHENBACH (203 Czech Republic); Jan HECKO (203 Czech Republic); Radek NEUWIRTH (203 Czech Republic, belonging to the institution) and Josef KAUTZNER (203 Czech Republic)
Edition
Radiation Oncology, LONDON, BMC, 2025, 1748-717X
Other information
Language
English
Type of outcome
Article in a journal
Field of Study
30201 Cardiac and Cardiovascular systems
Country of publisher
United Kingdom of Great Britain and Northern Ireland
Confidentiality degree
is not subject to a state or trade secret
References:
Impact factor
Impact factor: 3.300 in 2023
Organization unit
Faculty of Medicine
UT WoS
001440953100001
EID Scopus
2-s2.0-105000044729
Keywords in English
Radiosurgery; Refractory angina
Tags
International impact, Reviewed
Changed: 2/4/2025 12:36, Mgr. Tereza Miškechová
Abstract
V originále
BackgroundThis intervention pilot case series assessed 40-Gy stereotactic radiosurgery (SRS) neuromodulation applied to the bilateral stellate ganglion (SG) as a bailout procedure for patients with refractory angina pectoris (RAP).Materials and methodsThe local institutional review board approved this feasibility study. In three patients with RAP, after repeated good response, symptoms were temporarily relieved after anaesthetic blockade of the left SG under ultrasound guidance. Radiosurgical neuromodulation with a dose of 40 Gy in one fraction was used for more permanent pain control. When RAP recurred after the initial SRS, right-sided procedures were considered after a confirmed positive response to right SG anesthetic block.ResultsNo acute or late radiation-related toxicities were observed. Two patients (67%) responded to bilateral SRS (follow-up: 60 and 48 months, respectively). From baseline to 24 months, their average prescribed nitrate package count decreased from 5.5 to 0 and remained low. Daily emergency nitrates declined from 20 to 30 to 1-2 applications, and walking distance improved from 10 to 20 m to 200-400 m and remained stable. Quality of life as measured with the EQ-5D and all domains of the Seattle Angina Questionnaire improved. The third patient received only unilateral SRS, had a temporary improvement for 6 months before a return to baseline, and died after 42 months of follow-up.ConclusionsBilateral radiosurgical neuromodulation at 40 Gy appears to be feasible, safe, and effective as a bailout procedure for RAP.